Registered Trials
-
NCT05372588
Phase 3Australia
Total Enrollment: 1,340
Official Trial Registration:
-
NCT05249816
Phase 3United Arab Emirates
Total Enrollment: 1,000
Official Trial Registration:
-
NCT04611802
Phase 3Mexico, Puerto Rico, United States of America
Total Enrollment: 33,000
Official Trial Registration:
-
NCT05463068
Phase 3United States of America
Total Enrollment: 911
Official Trial Registration:
-
NCT05556720
Phase 3Australia
Total Enrollment: 960
Official Trial Registration:
-
EUCTR2020-004123-16, NCT04583995
Phase 3United Kingdom of Great Britain and Northern Ireland
Total Enrollment: 15,000
Official Trial Registration:
-
CTRI/2021/02/031554
Phase 2/3India
Total Enrollment: 1,600
Official Trial Registration:
-
NCT05236491
Phase 2/3Canada
Total Enrollment: 287
Official Trial Registration:
-
NCT05468736
Phase 2/3United States of America
Total Enrollment: 3,600
Official Trial Registration:
-
NCT05519839
Phase 2Australia, New Zealand
Total Enrollment: 2,300
Official Trial Registration:
-
ISRCTN73765130
Phase 2United Kingdom of Great Britain and Northern Ireland
Total Enrollment: 2,664
Official Trial Registration:
-
PACTR202203582920839
Phase 2Democratic Republic of the Congo, Kenya, Rwanda
Total Enrollment: 1,950
Official Trial Registration:
-
NCT05409261
Phase 2Mali
Total Enrollment: 400
Official Trial Registration:
-
NCT05112848
Phase 2South Africa
Total Enrollment: 360
Official Trial Registration:
-
NCT04533399
Phase 2South Africa
Total Enrollment: 4,400
Official Trial Registration:
-
NCT04961541
Phase 1/2Australia
Total Enrollment: 640
Official Trial Registration:
-
NCT04368988
Phase 1/2Australia, United States of America
Total Enrollment: 1,419
Official Trial Registration: